PHASE 1 DOSE ESCALATION TRIAL OF THE SAFETY OF BMX-001 CONCURRENT WITH RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED PATIENTS WITH HIGH-GRADE GLIOMAS
Published
Conference Paper
ACTR-28
Full Text
Duke Authors
Cited Authors
- Peters, K; Kirkpatrick, J; Batinic-Haberle, I; Affronti, M; Woodring, S; Iden, D; Panta, S; Lipp, E; Healy, P; Herndon, J; Spasojevic, I; Penchev, S; Gad, S; Siberstein, D; Johnson, M; Randazzo, D; Desjardins, A; Friedman, H; Ashley, D; Crapo, J
Published Date
- November 5, 2018
Published In
Volume / Issue
- 20 / suppl. 6; abstr QOLP-13
Start / End Page
- 1vi7 - vi17
Published By
Pages
- 1
Electronic International Standard Serial Number (EISSN)
- 1523-5866
International Standard Serial Number (ISSN)
- 1522-8517
Digital Object Identifier (DOI)
- 10.1093/neuonc/noy148.061
Conference Name
- 23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference
Conference Location
- New Orleans, LA
Conference Start Date
- November 14, 2018
Conference End Date
- November 18, 2018